Christine Mrakotsky, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 4 | 2023 | 9963 | 0.550 |
Why?
|
Emotions | 2 | 2020 | 2657 | 0.510 |
Why?
|
Cognition | 5 | 2022 | 6722 | 0.480 |
Why?
|
Adrenal Cortex Hormones | 4 | 2014 | 1847 | 0.470 |
Why?
|
Depressive Disorder | 4 | 2020 | 3748 | 0.380 |
Why?
|
Prednisone | 2 | 2012 | 1567 | 0.380 |
Why?
|
Brain Injuries | 1 | 2022 | 2024 | 0.370 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2684 | 0.330 |
Why?
|
Parents | 2 | 2020 | 3387 | 0.310 |
Why?
|
Behavior | 1 | 2011 | 560 | 0.310 |
Why?
|
Mianserin | 1 | 2007 | 52 | 0.290 |
Why?
|
Child Behavior | 1 | 2012 | 838 | 0.290 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2007 | 434 | 0.250 |
Why?
|
Phobic Disorders | 1 | 2007 | 439 | 0.240 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2014 | 2410 | 0.240 |
Why?
|
Neuropsychological Tests | 4 | 2022 | 6974 | 0.220 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4248 | 0.210 |
Why?
|
Abdominal Pain | 3 | 2020 | 1059 | 0.210 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1515 | 0.210 |
Why?
|
Psychophysiologic Disorders | 2 | 2014 | 228 | 0.200 |
Why?
|
Child | 16 | 2023 | 77478 | 0.190 |
Why?
|
Neuropsychology | 1 | 2019 | 109 | 0.160 |
Why?
|
Methylphenidate | 2 | 2014 | 473 | 0.160 |
Why?
|
Behavior Therapy | 2 | 2022 | 866 | 0.150 |
Why?
|
Adolescent | 13 | 2022 | 85649 | 0.150 |
Why?
|
Hemophilia A | 1 | 2019 | 351 | 0.140 |
Why?
|
Risperidone | 2 | 2008 | 383 | 0.130 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 6 | 2014 | 3649 | 0.130 |
Why?
|
Depressive Disorder, Major | 5 | 2004 | 4628 | 0.120 |
Why?
|
Executive Function | 1 | 2022 | 1362 | 0.120 |
Why?
|
Central Nervous System Stimulants | 2 | 2014 | 1148 | 0.120 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1499 | 0.110 |
Why?
|
Language | 1 | 2022 | 1458 | 0.110 |
Why?
|
Amphetamine | 1 | 2014 | 225 | 0.110 |
Why?
|
Attention | 1 | 2022 | 2396 | 0.100 |
Why?
|
Comorbidity | 6 | 2020 | 10372 | 0.100 |
Why?
|
Child, Preschool | 11 | 2020 | 40955 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1452 | 0.100 |
Why?
|
Epilepsy | 3 | 2014 | 3301 | 0.100 |
Why?
|
Bipolar Disorder | 2 | 2008 | 5024 | 0.090 |
Why?
|
Personality Inventory | 1 | 2012 | 1026 | 0.090 |
Why?
|
Self Report | 1 | 2020 | 3548 | 0.080 |
Why?
|
Child Development | 1 | 2019 | 2222 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9305 | 0.070 |
Why?
|
Humans | 24 | 2023 | 742088 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2007 | 6030 | 0.070 |
Why?
|
Family Health | 1 | 2011 | 1282 | 0.070 |
Why?
|
Depression | 3 | 2014 | 7733 | 0.070 |
Why?
|
Valproic Acid | 1 | 2008 | 446 | 0.060 |
Why?
|
Female | 15 | 2022 | 379592 | 0.060 |
Why?
|
Age Factors | 4 | 2011 | 18355 | 0.060 |
Why?
|
Dexamethasone | 1 | 2011 | 1949 | 0.060 |
Why?
|
Antipsychotic Agents | 2 | 2008 | 3058 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.060 |
Why?
|
Personality Assessment | 4 | 2008 | 643 | 0.060 |
Why?
|
Male | 15 | 2020 | 349538 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15194 | 0.060 |
Why?
|
Severity of Illness Index | 7 | 2014 | 15530 | 0.050 |
Why?
|
Pain Measurement | 1 | 2012 | 3418 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2014 | 2838 | 0.050 |
Why?
|
Anticonvulsants | 2 | 2010 | 1914 | 0.050 |
Why?
|
Affective Symptoms | 1 | 2004 | 407 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3339 | 0.050 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 807 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2007 | 2885 | 0.050 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 29 | 0.050 |
Why?
|
Pregnancy | 1 | 2022 | 29087 | 0.050 |
Why?
|
Adult | 3 | 2022 | 213712 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2012 | 1901 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 25575 | 0.040 |
Why?
|
Crohn Disease | 1 | 2012 | 2301 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35070 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2007 | 10943 | 0.040 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 3 | 2003 | 304 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40450 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2006 | 1174 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2003 | 3510 | 0.030 |
Why?
|
Brain | 1 | 2022 | 26343 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 53187 | 0.030 |
Why?
|
Pilot Projects | 1 | 2007 | 8297 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2004 | 1953 | 0.030 |
Why?
|
Headache | 1 | 2020 | 1219 | 0.030 |
Why?
|
Pediatrics | 1 | 2007 | 3462 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 24913 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2019 | 1895 | 0.020 |
Why?
|
Saliva | 2 | 2004 | 805 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40054 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 2999 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8621 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2003 | 4229 | 0.020 |
Why?
|
Migraine Disorders | 1 | 2020 | 1620 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2006 | 39004 | 0.020 |
Why?
|
Mental Disorders | 1 | 2007 | 6587 | 0.020 |
Why?
|
Sialorrhea | 1 | 2006 | 25 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2003 | 13921 | 0.020 |
Why?
|
Anxiety | 2 | 2014 | 4279 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2007 | 505 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2372 | 0.020 |
Why?
|
Hyperprolactinemia | 1 | 2006 | 129 | 0.020 |
Why?
|
Psychotherapy | 1 | 2014 | 1644 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2030 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2010 | 12017 | 0.020 |
Why?
|
Affect | 1 | 2012 | 1473 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1788 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2970 | 0.020 |
Why?
|
Frustration | 1 | 2003 | 22 | 0.020 |
Why?
|
Motivation | 1 | 2012 | 1968 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 72145 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2003 | 975 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2003 | 553 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2003 | 939 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2003 | 703 | 0.010 |
Why?
|
Life Change Events | 1 | 2004 | 937 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6142 | 0.010 |
Why?
|
Arousal | 1 | 2003 | 1165 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2003 | 12958 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4664 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2004 | 1825 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 4982 | 0.010 |
Why?
|
Weight Gain | 1 | 2006 | 2282 | 0.010 |
Why?
|
Income | 1 | 2004 | 1904 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10578 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56350 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19862 | 0.010 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2003 | 1442 | 0.010 |
Why?
|
Family | 1 | 2004 | 3144 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 77098 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10392 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14720 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 62966 | 0.000 |
Why?
|